CELL SIGNALING TECHNOLOGY search Cell Signaling Technology BCL2L1 products
includes other brands or spellings
|
| ic, ip, wb | | Cell Signaling Technology rabbit polyclonal anti-Bcl-xL antibody was used in western blot, immunoprecipitation and immunocytochemistry to study that overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. |
| wb | | Cell Signaling Technology anti-Bcl-xL antibody was used in western blot to study that kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via akt-glycogen synthase kinase-3 and akt-bad·14-3-3 signaling pathways. |
| wb | | Cell Signaling Technology rabbit anti-human Bcl-xL antibody was used in western blot to detect Bcl-xL in LNCaP cells transfected with Bcl-xL. |
| wb | | Cell Signaling Technology anti-BCL-xL antibody was used in western blot to detect the mitochondrial and total cellular levels of BCL-xL in P388D1 cells with different amounts of 25-OHC treat for 12 h. |
| wb | | Cell Signaling rabbit polyclonal anti-Bcl-xL antibody was used in western blot to detect Bcl-xL in K562-R, LAMA-R and their parent cells treated with 1 µM imatinib mesylate. |
| wb | | Cell Signaling anti-BCL-XL antibody was used in western blot to detect BCL-XL in HT-29 cells treated with NMT1-1 siRNA or NMT2-4 siRNA. |
| wb | | Cell Signaling anti-Bcl-xL antibody was used in western blot to study the Reduced expression of Bcl-xL after IgM cross-linking on B cells of PKCß-/- compared with control mice. |
| wb | | Cell Signaling Technology anti-Bcl-xL antibody was used in western blot to study the relationship between FPR expression and the biologic behavior of glioma cells. |
| wb | | New England BioLabs Bcl-XL antibody was used in western blot to study the mechanism by which WISP-1 promotes tumorigenicity. |
| wb | | Cell Signaling Technology rabbit polyclonal Bcl-xL antibody was used in western blot to study the effect on BAD phosphorylation and Bcl-2 association by Raf-1 phosphorylation. |
| wb | | Cell Signaling Bcl-xL antibody was used in western blot to study apoptotic cell death in prostate cancer caused by androgen receptor silencing. |
SIGMA-ALDRICH search Sigma-Aldrich BCL2L1 products
includes other brands or spellings
|
| wb | | Sigma anti-Bcl-XL antibody was used in western blot to detect Bcl-XL in BdGBM cells. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology BCL2L1 products
includes other brands or spellings
|
| flow, wb | | Santa Cruz Biotechnology mouse anti-human Bcl-xL antibody was used in western blot and flow cytometry to analyze the expression of Bcl-xL in high density, CD27-depleted tonsil B lymphocytes and lysates of CD40-activated human follicular B cells from human tonsil tissue of 3- to 15-year-old donors. |
| ic, wb | | Santa Cruz Biotechnology mouse monoclonal anti-Bcl-xL antibody sc-8392 was used in western blot and immunocytochemistry to study the expression of proapoptotic factor Nix and Bcl-xL during terminal erythroid differentiation. |
| ih | | Santa Cruz Biotechnology goat polyclonal anti-Bcl-xL antibody was used to study the localization and expression of cx-26, Bcl-xL and Bax proteins in colorectal cancer. |
| ih | | Santa Cruz Bcl-X/L (H-62) polyclonal antibody was used in immunohistochemistry to detect Bcl-X/L in cytoplasm of human esophageal squamous cell carcinoma. |
| ip, wb | | Santa Cruz Biotechnology rabbit anti-BCL-XL polyclonal antibody was used in immunoprecipitation and anti-BCL-XL mouse monoclonal antibody used in western blot to study the function of FAST as a survival protein with ability to sense mitochondrial stress and modulate TIA-1-regulated changes in protein expression. |
| wb | | Santa Cruz Biotechnology anti-BCL-xL antibody was used in western blot to study that PIM-2 kinase phosphorylates BAD on Serine 112 and reverses BAD-induced cell death. |
| wb | | Santa Cruz Biotechnology anti-Bcl-xL antibody SC-634 was used in western blot to study the effect of p53-independent NOXA induction on apoptotic resistance of malignant melanomas. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal anti-Bcl-XL antibody S-18 was used in human T-cell lymphoblastic leukemia cell line CCRF-HSB-2 cells and in western blot to study the taxol-induced caspase-10-dependent apoptosis. |
| wb | | Santa Cruz Biotechnology anti–bcl-xL was used in western blot to detect bcl-xL in Jurkat cells. |
| wb | | Santa Cruz Biotechnology Bcl-XL antibody was used in western blot to study apoptotic induction by apicidin in human Bcr-Abl-positive leukemia cells. |
| wb | | Santa Cruz Biotechnology anti-Bcl-XL antibody was used in human Jurkat cells and in western blot to study the effect of granzyme B on Mcl-1. |
| wb | | Santa Cruz Biotechnology rabbit anti-BCL-xL/S antibody was used in western blot to study the CSF-independent human macrophages survival. |
| wb | | Santa Cruz Biotechnology Bcl-xL antibody was used in western blot to study the role of Cyr61 in endometrial tumorigenesis. |
| wb | | Santa Cruz Biotechnology BCL-XS/L antibody was used in western blot to study the induction of the BCL-6 transcriptional repressor by forkhead transcription factor AFX. |
| wb | | Santa Cruz Biotechnology rabbit polyclonal Bcl-xL antibody was used in western blot to study the interactions between pharmacological MEK1/2 inhibitors and STI571 in Bcr/Abl-positive human leukemia cells. |
| wb | | SCBT anti-Bcl-XL antibody was used in western blot to study the induction of neuroblastoma cell apoptosis by TrkA. |
R & D SYSTEMS search R & D Systems BCL2L1 products
includes other brands or spellings
|
| wb | | Santa Cruz Biotechnology anti-Bcl-xL antibody was used in western blot to detect Bcl-xL in wild-type Jurkat and Jurkat cells stably transfected with Bcl-xL or vector control cells. |
BD BIOSCIENCES search BD Biosciences BCL2L1 products
includes other brands or spellings
|
| wb | | BD Biosciences anti-Bcl-xL antibody was used in western blot to study the effects of TL1A-induced NF- B and c-IAP2 on DR3-mediated apoptosis in TF-1 cells. |
| wb | | BD Biosciences anti-Bcl-XL antibody was used in western blot to study the function of protein phosphatase subunit G5PR in B cell receptor–induced apoptosis. |
| wb | | BD transduction Laboratories anti-Bcl-xL antibody was used in human T-cell leukemia cell lines and in western blot to study the effect of Jak-Stat pathway on cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. |
| wb | | Transduction Laboratories rabbit anti-BCL-X antibody was used in western blot to study the CSF-independent human macrophages survival. |
| wb | | BD Biosciences monoclonal mouse anti-Bcl-xL antibody was used in western blot to study dendritic cell apoptosis in the maintenance of immune tolerance. |
MILLIPORE search Millipore BCL2L1 products
includes other brands or spellings
|
| ih | | Chemicon BCL2L1 antibody was tested in immunohistochemistry by HPA (CAB000105) . |
TREVIGEN search Trevigen BCL2L1 products
|
| wb | | Trevigen anti-Bcl-XL antibody was used in western blot to detect Bcl-XL in U937 cells incubated for 24 h with 1-mM SB or 2-µM SAHA ± 100-ng/ml TRAIL in the absence or presence of the pan-caspase inhibitor BOC-D-fmk. |
BECKMAN COULTER search Beckman Coulter BCL2L1 products
includes other brands or spellings
|
| ih | | DAKO Corp mouse monoclonal anti-bcl-2 antibody (clone 124) was used in immunohistochemistry to study the effect of hypoxia on erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its role in cervical carcinogenesis and tumor progression. |
Articles Reviewed |
| 1. Tracy Tzu-Ling Tang et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. 2002 |
| 2. Chunrong Yu et al. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. 2002 |
| 3. Fei Su et al. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. 2002 |
| 4. Kaoru Saijo et al. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. 2002 |
| 5. Makoto Kamachi et al. Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. 2002 |
| 6. Ming-Yao Wu et al. Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions. 2002 |
| 7. Atsushi Saito et al. Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. 2003 |
| 8. Wulin Aerbajinai et al. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. 2003 |
| 9. Chih-Cheng Yang et al. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells. 2003 |
| 10. Geza Acs et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. 2003 |
| 11. Pierre-François Cartron et al. Nonredundant role of Bax and Bak in Bid-mediated apoptosis. 2003 |
| 12. Leng Wen et al. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. 2003 |
| 13. Bin Yan et al. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. 2003 |
| 14. Antonio E Rusiñol et al. AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. 2004 |
| 15. June-Won Cheong et al. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. 2003 |
| 16. Patricia K A Mongini et al. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. 2003 |
| 17. Roberto R Rosato et al. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. 2003 |
| 18. Alberto Ballestrero et al. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 2004 |
| 19. Jie Han et al. Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events. 2004 |
| 20. Yun Dai et al. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. 2004 |
| 21. Jian-Zhong Qin et al. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. 2004 |
| 22. Soo-Jung Park et al. Taxol induces caspase-10-dependent apoptosis. 2004 |
| 23. Wenwen Chien et al. Cyr61 suppresses growth of human endometrial cancer cells. 2004 |
| 24. Wei Li et al. FAST is a survival protein that senses mitochondrial stress and modulates TIA-1-regulated changes in protein expression. 2004 |
| 25. Hang Yin et al. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. 2005 |
| 26. Luiza Kanczuga-Koda et al. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer. 2005 |
| 27. Xinbo Liao et al. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. 2005 |
| 28. Shenghao Jin et al. p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association. 2005 |
| 29. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005 |
| 30. Jean-François Lavoie et al. TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. 2005 |
| 31. Charles E Ducker et al. Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis. 2005 |
| 32. Yan Xing et al. Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis. 2005 |
| 33. Iwao Komuro et al. Catalase plays a critical role in the CSF-independent survival of human macrophages via regulation of the expression of BCL-2 family. 2005 |
| 34. Min Chen et al. Dendritic cell apoptosis in the maintenance of immune tolerance. 2006 |
| 35. Mariko Tomita et al. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. 2006 |
| 36. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |